HPV 16 Infection
8 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Study of Human Papillomavirus (HPV) 16 Vaccine in the Prevention of HPV 16 Infection in 16- to 23-Year-Old Females (V501-005) (NCT00365378) | Merck Sharp & Dohme LLC | 1999-09-01 |
Track HPV 16 Infection automatically
Every clearance here is in the API, with alerts when new ones post.